BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8701532)

  • 21. [High-dose chemotherapy with autologous bone marrow transplantation in the treatment of small cell carcinoma of the lung].
    Luo KH; Sun Y; Wu GQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Oct; 15(5):306-8. PubMed ID: 1339111
    [No Abstract]   [Full Text] [Related]  

  • 22. High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes.
    Lalisang RI; Hupperets PS; ten Haaft MA; Jansen RL; Schouten HC
    Bone Marrow Transplant; 1998 Feb; 21(3):243-7. PubMed ID: 9489646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of high-dose chemotherapy and autologous stem cell support in treatment of breast cancer.
    Myers SE; Williams SF
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):631-45. PubMed ID: 8102137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autotransplantation for solid tumors].
    Lorenz F; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():101-7. PubMed ID: 10494190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.
    McGuire WP
    Curr Probl Cancer; 1998; 22(3):135-77. PubMed ID: 9659570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
    Maraninchi D; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.
    Hanrahan EO; Broglio K; Frye D; Buzdar AU; Theriault RL; Valero V; Booser DJ; Singletary SE; Strom EA; Gajewski JL; Champlin RE; Hortobagyi GN
    Cancer; 2006 Jun; 106(11):2327-36. PubMed ID: 16639731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
    Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
    J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
    Zander AR; Kröger N; Schmoor C; Krüger W; Möbus V; Frickhofen N; Metzner B; Schultze W; Berdel WE; Koenigsmann M; Thiel E; Wandt H; Possinger K; Trümper L; Kreienberg R; Carstensen M; Schmidt EH; Jänicke F; Schumacher M; Jonat W
    J Clin Oncol; 2004 Jun; 22(12):2273-83. PubMed ID: 15111618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.
    Hohaus S; Funk L; Martin S; Schlenk RF; Abdallah A; Hahn U; Egerer G; Goldschmidt H; Schneeweiss A; Fersis N; Kaul S; Wallwiener D; Bastert G; Haas R
    Br J Cancer; 1999 Mar; 79(9-10):1500-7. PubMed ID: 10188897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose chemotherapy supported by autologous bone marrow transplantation in solid tumors.
    Tajima T; Sonoda H; Tokuda Y; Kubota M; Sugita T; Nakasaki H; Yokoyama S; Mitomi T; Kondo K; Shioya S; Watanabe K; Nagao T
    Tokai J Exp Clin Med; 1983 Jan; 8(1):41-51. PubMed ID: 6351354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.
    Pedrazzoli P; Rosti G; Secondino S; Carminati O; Demirer T; ; ;
    Semin Hematol; 2007 Oct; 44(4):286-95. PubMed ID: 17961729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy.
    Bitran JD; Samuels B; Trujillo Y; Klein L; Schroeder L; Martinec J
    Clin Cancer Res; 1996 Sep; 2(9):1509-13. PubMed ID: 9816327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High-dose chemotherapy for metastatic breast cancer].
    Lalle M; De Rosa L; Perillo A; Scambia G; D'Aprile M; Antimi M
    Clin Ter; 2004; 155(7-8):305-15. PubMed ID: 15553258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose therapy in breast cancer: out of favor but not out of promise.
    Glück S; Stewart D
    Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intensive chemotherapy with bone marrow autograft in solid tumors].
    Sculier JP; Stryckmans P; Klastersky J
    Rev Med Brux; 1983 Jun; 4(6):409-15. PubMed ID: 6308742
    [No Abstract]   [Full Text] [Related]  

  • 39. [Decentralized high-dose cytostatic treatment with autologous stem cell support].
    Husebekk A; Kolstad A; Dahl IM; Skogen B
    Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2777-80. PubMed ID: 9748807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
    Brockstein BE; Williams SF
    Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.